The studies conducted so far show that PCMT1 expression is correlated with the advanced tumor stage of breast cancer and that the association with immune-infiltration biomarkers suggest that it may be a prognostic marker of breast cancer. The gene discussed is PCMT1; the disease is breast cancer.